Figure 1.
Genomic study cohort CONSORT diagram. The flow diagram shows the genomic lesions identified in patients with B-ALL (n = 40) and those with T-ALL (n = 17) comprising the genomic study cohort. Patients are grouped according to AR vs SR genomic lesions, then by MRD status at TP2 (day 79) and transplant status. Note that 1 patient with T-ALL experienced toxicity and died early in the treatment course (NUP214rD∗) and does not appear in the posttransplant section of the flow diagram. neg, negative; pos, positive.

Genomic study cohort CONSORT diagram. The flow diagram shows the genomic lesions identified in patients with B-ALL (n = 40) and those with T-ALL (n = 17) comprising the genomic study cohort. Patients are grouped according to AR vs SR genomic lesions, then by MRD status at TP2 (day 79) and transplant status. Note that 1 patient with T-ALL experienced toxicity and died early in the treatment course (NUP214rD∗) and does not appear in the posttransplant section of the flow diagram. neg, negative; pos, positive.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal